feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Scientists Engineer 'Super Soldiers' to Battle Cancer

Scientists Engineer 'Super Soldiers' to Battle Cancer

9 Dec, 2025

•

Summary

  • T-cells are engineered to attack cancerous cells specifically.
  • A multi-step genetic modification ensures therapy's self-preservation.
  • Successful treatment leads to a bone marrow transplant.
Scientists Engineer 'Super Soldiers' to Battle Cancer

Scientists have developed a revolutionary T-cell therapy that engineers the body's own immune cells to fight cancer. This complex process involves genetically modifying T-cells to precisely target and eliminate cancerous cells while simultaneously protecting themselves from destruction.

The therapy involves multiple genetic edits. These include disabling the T-cells' natural targeting mechanism to prevent attacks on the patient's body, removing a specific marker (CD7) to avoid self-destruction, and creating an 'invisibility cloak' against chemotherapy drugs.

Once infused, these modified T-cells hunt any cell bearing the CD7 marker, effectively destroying cancer cells. If cancer is undetectable after four weeks of treatment, patients undergo a bone marrow transplant to rebuild their immune system, marking a significant advance in cancer treatment.

trending

Fatal mountain lion attack reported

trending

Musk defiant on Tesla CEO

trending

Derrick White leads Celtics victory

trending

California coastal flood warning issued

trending

Adelaide 36ers defeat Sydney

trending

Kraken defeat Predators 4-1

trending

Apple stock strong Q3 performance

trending

Analyst bullish on Alphabet stock

trending

Blackhawks beat slumping Stars

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Scientists modify T-cells genetically to target cancer cells, remove self-attack mechanisms, and evade chemotherapy.
It's a genetic modification that prevents engineered T-cells from being destroyed by chemotherapy drugs.
A bone marrow transplant is performed if cancer remains undetectable after four weeks of T-cell treatment.

Read more news on

Healthside-arrow

You may also like

Gene Therapy Revolution: From Rare Diseases to Mainstream Care

8 hours ago • 29 reads

article image

Cancer Patients Fund Own Chemo Amid NHS Wait Woes

21 Dec, 2025 • 76 reads

article image

Cancer Patient Misses Parties Due to Chemo Side Effects

20 Dec, 2025 • 79 reads

article image

Roche Drug Slashes Breast Cancer Recurrence by 30%

10 Dec, 2025 • 172 reads

article image

Parkinson's Reversed: Stem Cells Offer New Hope

8 Dec, 2025 • 130 reads

article image